Literature DB >> 27455453

The role of anaerobic bacteria in the cystic fibrosis airway.

Laura J Sherrard1, Scott C Bell, Michael M Tunney.   

Abstract

PURPOSE OF REVIEW: Anaerobic bacteria are not only normal commensals, but are also considered opportunistic pathogens and have been identified as persistent members of the lower airway community in people with cystic fibrosis of all ages and stages of disease. Currently, the role of anaerobic bacteria in cystic fibrosis lower airway disease is not well understood. Therefore, this review describes the recent studies relating to the potential pathophysiological role(s) of anaerobes within the cystic fibrosis lungs. RECENT
FINDINGS: The most frequently identified anaerobic bacteria in the lower airways are common to both cystic fibrosis and healthy lungs. Studies have shown that in cystic fibrosis, the relative abundance of anaerobes fluctuates in the lower airways with reduced lung function and increased inflammation associated with a decreased anaerobic load. However, anaerobes found within the lower airways also produce virulence factors, may cause a host inflammatory response and interact synergistically with recognized pathogens.
SUMMARY: Anaerobic bacteria are potentially members of the airway microbiota in health but could also contribute to the pathogenesis of lower airway disease in cystic fibrosis via both direct and indirect mechanisms. A personalized treatment strategy that maintains a normal microbial community may be possible in the future.

Entities:  

Mesh:

Year:  2016        PMID: 27455453     DOI: 10.1097/MCP.0000000000000299

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  14 in total

1.  Fungal and Bacterial Diversity of Airway Microbiota in Adults with Cystic Fibrosis: Concordance Between Conventional Methods and Ultra-Deep Sequencing, and Their Practical use in the Clinical Laboratory.

Authors:  Françoise Botterel; Cécile Angebault; Odile Cabaret; Franziska A Stressmann; Jean-Marc Costa; Frédéric Wallet; Benoit Wallaert; Kenneth Bruce; Laurence Delhaes
Journal:  Mycopathologia       Date:  2017-08-01       Impact factor: 2.574

2.  Comparison of Oropharyngeal Microbiota from Children with Asthma and Cystic Fibrosis.

Authors:  Sébastien Boutin; Martin Depner; Mirjam Stahl; Simon Y Graeber; Susanne A Dittrich; Antje Legatzki; Erika von Mutius; Marcus Mall; Alexander H Dalpke
Journal:  Mediators Inflamm       Date:  2017-12-27       Impact factor: 4.711

3.  Individual Patterns of Complexity in Cystic Fibrosis Lung Microbiota, Including Predator Bacteria, over a 1-Year Period.

Authors:  Juan de Dios Caballero; Rafael Vida; Marta Cobo; Luis Máiz; Lucrecia Suárez; Javier Galeano; Fernando Baquero; Rafael Cantón; Rosa Del Campo
Journal:  mBio       Date:  2017-09-26       Impact factor: 7.867

Review 4.  Acquisition and adaptation of the airway microbiota in the early life of cystic fibrosis patients.

Authors:  Sébastien Boutin; Alexander H Dalpke
Journal:  Mol Cell Pediatr       Date:  2017-01-17

5.  Fluctuations in airway bacterial communities associated with clinical states and disease stages in cystic fibrosis.

Authors:  Lisa A Carmody; Lindsay J Caverly; Bridget K Foster; Mary A M Rogers; Linda M Kalikin; Richard H Simon; Donald R VanDevanter; John J LiPuma
Journal:  PLoS One       Date:  2018-03-09       Impact factor: 3.240

6.  Microbiome networks and change-point analysis reveal key community changes associated with cystic fibrosis pulmonary exacerbations.

Authors:  Mehdi Layeghifard; Hannah Li; Pauline W Wang; Sylva L Donaldson; Bryan Coburn; Shawn T Clark; Julio Diaz Caballero; Yu Zhang; D Elizabeth Tullis; Yvonne C W Yau; Valerie Waters; David M Hwang; David S Guttman
Journal:  NPJ Biofilms Microbiomes       Date:  2019-01-21       Impact factor: 7.290

7.  Anaerobiosis influences virulence properties of Pseudomonas aeruginosa cystic fibrosis isolates and the interaction with Staphylococcus aureus.

Authors:  Ross Pallett; Laura J Leslie; Peter A Lambert; Ivana Milic; Andrew Devitt; Lindsay J Marshall
Journal:  Sci Rep       Date:  2019-05-01       Impact factor: 4.379

8.  The Lung Microbiome in Young Children with Cystic Fibrosis: A Prospective Cohort Study.

Authors:  Barry Linnane; Aaron M Walsh; Calum J Walsh; Fiona Crispie; Orla O'Sullivan; Paul D Cotter; Michael McDermott; Julie Renwick; Paul McNally
Journal:  Microorganisms       Date:  2021-02-26

9.  Association Between Number of Intravenous Antipseudomonal Antibiotics and Clinical Outcomes of Pediatric Cystic Fibrosis Pulmonary Exacerbations.

Authors:  Jonathan D Cogen; Anna V Faino; Frankline Onchiri; Lucas R Hoffman; Matthew P Kronman; David P Nichols; Margaret Rosenfeld; Ronald L Gibson
Journal:  Clin Infect Dis       Date:  2021-11-02       Impact factor: 20.999

10.  Impact of Anaerobic Antibacterial Spectrum on Cystic Fibrosis Airway Microbiome Diversity and Pulmonary Function.

Authors:  Michael J Bozzella; Hollis Chaney; Iman Sami; Anastassios Koumbourlis; James E Bost; Edith T Zemanick; Robert J Freishtat; Keith A Crandall; Andrea Hahn
Journal:  Pediatr Infect Dis J       Date:  2021-11-01       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.